Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)

Clinical trial NCT00776165 · COMPLETED

Trial details

NCT number: NCT00776165
Sponsor: Shantha Biotechnics Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-Induced Neutropenia

Start date: 2007-10-01
Primary completion: 2009-07-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.